Matches in Nanopublications for { ?s ?p "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185088.RAuv6g2E5qDLTby_xJErA_yTVTQ_IaVsdq1Q8z6zZT-DI130_provenance.
- NP258214.RAK0NkQccUwIpCbvjgefT5Btm5GyPMAdTa_VpKf28fBC8130_assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258214.RAK0NkQccUwIpCbvjgefT5Btm5GyPMAdTa_VpKf28fBC8130_provenance.
- NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858029.RAALw0H0wrDQlHdMXpCc7obarD625XJ2L1Sq938O91x3w130_provenance.
- NP232447.RAjzmA7awziHlzZwu3Dc3C5vbstRR8C-uWqKOqs8B0SYM130_assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232447.RAjzmA7awziHlzZwu3Dc3C5vbstRR8C-uWqKOqs8B0SYM130_provenance.
- NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232479.RAudqzRHg_lMSdBqj1eROjHtWjEiTJck9VG6QaC1jBLis130_provenance.
- NP858030.RAH1bByNkuaUOTCIQnfad-wY_I5npHhqBzj66sjYLUR6k130_assertion description "[Inhibitors of lipogenic signaling, including those that inhibit the AKT pathway, might be useful as therapeutics for patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858030.RAH1bByNkuaUOTCIQnfad-wY_I5npHhqBzj66sjYLUR6k130_provenance.